Tessenderlo Group Resultados de beneficios anteriores
Pasado controles de criterios 2/6
Tessenderlo Group has been growing earnings at an average annual rate of 7.3%, while the Chemicals industry saw earnings declining at 3.8% annually. Revenues have been growing at an average rate of 13.1% per year. Tessenderlo Group's return on equity is 4.7%, and it has net margins of 3.3%.
Información clave
7.3%
Tasa de crecimiento de los beneficios
2.6%
Tasa de crecimiento del BPA
| Crecimiento de la industria Chemicals | 4.3% |
| Tasa de crecimiento de los ingresos | 13.1% |
| Rentabilidad financiera | 4.7% |
| Margen neto | 3.3% |
| Próxima actualización de resultados | 26 Mar 2025 |
Actualizaciones de resultados anteriores recientes
Recent updates
Desglose de ingresos y gastos
Cómo gana y gasta dinero Tessenderlo Group. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Jun 24 | 2,691 | 90 | 412 | 0 |
| 31 Mar 24 | 2,810 | 100 | 409 | 0 |
| 31 Dec 23 | 2,928 | 110 | 407 | 0 |
| 30 Sep 23 | 2,901 | 127 | 399 | 0 |
| 30 Jun 23 | 2,874 | 144 | 390 | 0 |
| 31 Mar 23 | 2,731 | 185 | 370 | 0 |
| 31 Dec 22 | 2,588 | 227 | 349 | 0 |
| 30 Sep 22 | 2,494 | 241 | 341 | 0 |
| 30 Jun 22 | 2,400 | 254 | 332 | 0 |
| 31 Mar 22 | 2,241 | 221 | 319 | 0 |
| 31 Dec 21 | 2,082 | 188 | 307 | 0 |
| 30 Sep 21 | 1,952 | 149 | 293 | 0 |
| 30 Jun 21 | 1,823 | 110 | 280 | 0 |
| 31 Mar 21 | 1,780 | 105 | 278 | 0 |
| 31 Dec 20 | 1,737 | 99 | 277 | 0 |
| 30 Sep 20 | 1,745 | 118 | 278 | 0 |
| 30 Jun 20 | 1,753 | 136 | 280 | 0 |
| 31 Mar 20 | 1,748 | 116 | 282 | 0 |
| 31 Dec 19 | 1,743 | 96 | 284 | 0 |
| 30 Sep 19 | 1,722 | 90 | 281 | 0 |
| 30 Jun 19 | 1,701 | 83 | 279 | 0 |
| 31 Mar 19 | 1,661 | 87 | 275 | 0 |
| 31 Dec 18 | 1,621 | 92 | 272 | 0 |
| 30 Sep 18 | 1,599 | 77 | 272 | 0 |
| 30 Jun 18 | 1,578 | 63 | 272 | 0 |
| 31 Mar 18 | 1,618 | 44 | 275 | 0 |
| 31 Dec 17 | 1,657 | 26 | 278 | 0 |
| 30 Sep 17 | 1,658 | 51 | 273 | 0 |
| 30 Jun 17 | 1,660 | 76 | 268 | 0 |
| 31 Mar 17 | 1,625 | 87 | 262 | 0 |
| 31 Dec 16 | 1,590 | 99 | 257 | 0 |
| 30 Sep 16 | 1,592 | 91 | 260 | 0 |
| 30 Jun 16 | 1,594 | 84 | 263 | 0 |
| 31 Mar 16 | 1,592 | 84 | 263 | 0 |
| 31 Dec 15 | 1,589 | 85 | 263 | 0 |
| 30 Sep 15 | 1,539 | 65 | 260 | 0 |
| 30 Jun 15 | 1,509 | 70 | 253 | 0 |
| 31 Mar 15 | 1,471 | 62 | 248 | 0 |
| 31 Dec 14 | 1,434 | 54 | 243 | 0 |
| 30 Sep 14 | 1,461 | 35 | 245 | 0 |
| 30 Jun 14 | 1,537 | -4 | 255 | 0 |
| 31 Mar 14 | 1,691 | -52 | 277 | 0 |
| 31 Dec 13 | 1,790 | -64 | 295 | 0 |
Ingresos de calidad: TESBB has high quality earnings.
Margen de beneficios creciente: TESBB's current net profit margins (3.3%) are lower than last year (5%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: TESBB's earnings have grown by 7.3% per year over the past 5 years.
Acelerando crecimiento: TESBB's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Beneficios vs. Industria: TESBB had negative earnings growth (-37.7%) over the past year, making it difficult to compare to the Chemicals industry average (-36.8%).
Rentabilidad financiera
Alta ROE: TESBB's Return on Equity (4.7%) is considered low.